Microbiome: B. fragilis and the brain.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer's disease continuum.Alzheimer's research & therapy · 2025
   Article
2. A review on gut microbiota and miRNA crosstalk: implications for Alzheimer's disease.GeroScience · 2025
   Review
3. Concurrent Prebiotic Intake Reverses Insulin Resistance Induced by Early-Life Pulsed Antibiotic in Rats.Biomedicines · 2021
   Article
4. Gastrointestinal (GI)-Tract Microbiome Derived Neurotoxins and their Potential Contribution to Inflammatory Neurodegeneration in Alzheimer's Disease (AD).Journal of Alzheimer's disease & Parkinsonism · 2021
   Article
5. Metabolic and Neural Mechanisms Underlying the Associations Between GutFrontiers in neuroscience · 2021
   Article
6. Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration.Molecular neurobiology · 2018
   Review
7. Microbiome-Derived Lipopolysaccharide (LPS) Selectively Inhibits Neurofilament Light Chain (NF-L) Gene Expression in Human Neuronal-Glial (HNG) Cells in Primary Culture.Frontiers in neuroscience · 2018
   Article
8. Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer's Disease.Frontiers in neurology · 2018
   Article
9. Outer membrane vesicles secreted by pathogenic and nonpathogenic Bacteroides fragilis represent different metabolic activities.Scientific reports · 2017
   Article
10. Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus.Frontiers in cellular and infection microbiology · 2017
    Review
11. Frontiers in microbiology · 2016
    Article

Corrections and comments

• Comment on
  Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as